We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms

By HospiMedica International staff writers
Posted on 30 Jun 2022

Many who experience what is now called ‘long-COVID’ report feeling brain fog, breathless, fatigued and limited in doing everyday things, often lasting weeks and months post-infection. More...

Now, for the first time, using functional MRI with inhaled xenon gas, researchers have shown that these debilitating symptoms are related to microscopic abnormalities which affect how oxygen is exchanged from the lungs to the red blood cells.

The LIVECOVIDFREE study led by researchers at Western University (Ontario, Canada) is the largest MRI study of patients with long-COVID and also the first to show a potential cause of long-COVID symptoms. By understanding the cause, team members responsible for patient care have been able to target treatment for these patients. For the study, the researchers recruited patients with suspected long-COVID who were experiencing persistent shortness of breath more than six weeks post-infection. Some study participants were still symptomatic after 35 weeks. The patients who were describing these symptoms were also showing normal results on clinical breathing tests.

By having the study participants inhale polarized xenon gas while inside the MRI, the researchers could see in real-time the function of the 300-500 million tiny alveolar sacs, which are about 1/5 of a mm in diameter and responsible for delivering oxygen to the blood. Further CT scans pointed to ‘abnormal trimming’ of the vascular tree, indicating an impact on the tiny blood vessels that deliver red blood cells to the alveoli to be oxygenated. There also appeared to be no difference in severity of this abnormality between patients who had been hospitalized with COVID-19, and those who recovered without hospitalization, according to the study. This is an important finding as the latest wave of COVID-19 infection has affected large numbers of people who did not need hospital-based care. A one-year follow-up is now underway to better understand these results longitudinally.

“With our MRI technique, we can watch in real-time the air moving through the alveolar membrane and through to the blood cells; and we can actually see the function of the tiny alveolar sacs in the lungs,” said Western University professor Grace Parraga who led the study. “What we saw on the MRI was that the transition of the oxygen into the red blood cells was depressed in these symptomatic patients who had had COVID-19, compared to healthy volunteers.”

“For those who are symptomatic post-COVID, even if they hadn’t had a severe enough infection to be hospitalized, we are seeing this abnormality in the exchange of oxygen across the alveolar membrane into the red blood cells,” added Parraga.

Related Links:
Western University 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.